Showing results (241-250 of 297) with videos related to
Sort By:
Pageof 30
Scientific Reports|December 5, 2020
Longitudinal analysis of total serum IgE levels with allergen sensitization and atopic diseases in early childhoodChun-Ying Wong, Kuo-Wei Yeh, Jing-Long Huang, et al.Rheumatology International|July 3, 2013
Survival impact of serum uric acid levels in children and adolescentsShao-Hsuan Hsia, I-Jun Chou, Chang-Fu Kuo, et al.Frontiers in Immunology|July 17, 2020
Lower T Regulatory and Th17 Cell Populations Predicted by RT-PCR-Amplified <i>FOXP3</i> and <i>ROR</i>γ<i>t</i> Genes Are Not Rare in Patients With Primary Immunodeficiency DiseasesWen-I Lee, Jing-Long Huang, Syh-Jae Lin, et al.Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi|June 28, 2008
Current classification and status of primary immunodeficiency diseases in TaiwanFang-Chen Liang, Yi-Chia Wei, Tang-Her Jiang, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 15, 2017
Longitudinal vitamin D deficiency is inversely related to mite sensitization in early childhoodChih-Yung Chiu, Kuan-Wen Su, Ming-Han Tsai, et al.Cell Transplantation|November 10, 2021
High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDSHuei-Yu Lo, Shun-Ping Cheng, Jing-Long Huang, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 26, 2020
Oxidative stress is associated with atopic indices in relation to childhood rhinitis and asthmaCheryn Yu Wei Choo, Kuo-Wei Yeh, Jing-Long Huang, et al.Metabolites|February 25, 2022
Longitudinal Metabolomic Analysis Reveals Gut Microbial-Derived Metabolites Related to Formula Feeding and Milk Sensitization Development in InfancyChing-Min Tang, Gigin Lin, Meng-Han Chiang, et al.Medicine|December 30, 2018
Risk factors for child maltreatment by the utilization of medical service and socioeconomic environment in TaiwanYi-Chen Hsin, Yu-Ching Chang, En-Pei Lee, et al.Cancer Immunology, Immunotherapy : CII|November 20, 2025
Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR/MSS refractory metastatic colorectal cancer: a phase 2 clinical trialWen Zhang, Cai-Feng Gong, Jing-Long Huang, et al.Pageof 30